Invention Grant
- Patent Title: Aqueous pharmaceutical formulation comprising propofol
-
Application No.: US16073580Application Date: 2017-01-25
-
Publication No.: US10646439B2Publication Date: 2020-05-12
- Inventor: Christopher Mengler
- Applicant: Cuda Anesthetics, LLC
- Applicant Address: US NY Douglas Manor
- Assignee: Cuda Anesthetics, LLC
- Current Assignee: Cuda Anesthetics, LLC
- Current Assignee Address: US NY Douglas Manor
- Agency: Sterne, Kessler, Goldstein & Fox, P.L.L.C.
- International Application: PCT/US2017/014909 WO 20170125
- International Announcement: WO2017/132243 WO 20170803
- Main IPC: A61K31/045
- IPC: A61K31/045 ; A61K9/08 ; A61K31/05 ; A61K31/724 ; A61P23/00 ; A61K9/00 ; A61K47/12 ; A61K47/40
Abstract:
Disclosed herein is an aqueous pharmaceutical formulation comprising about 10 mg/mL of propofol, 175 mg/mL of sulfobutylether β-cyclodextrin, a citric buffer, wherein the composition has a pH of about 5.5. Also disclosed is a method of inducing and maintaining anesthesia or sedation in a patient by administering the aqueous pharmaceutical formulation.
Public/Granted literature
- US20190060232A1 AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING PROPOFOL Public/Granted day:2019-02-28
Information query
